Skip to content

Effects of parenteral nutrition with Olive and MCT/LCT based lipid emulsions on immune function in esophageal cancer patient undergoing surgery

Effects of parenteral nutrition with Olive and MCT/LCT based lipid emulsions on immune function in esophageal cancer patient undergoing surgery: A prospective, controlled, randomized,blinded, paralleled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003562
Enrollment
Unknown
Registered
2013-08-29
Start date
2013-09-05
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Study group:All-in-one bags,fat emulsion is olive-oil-based lipid emulsion (ClinOleic)
control group:All-in-one bags,fat emulsion is LCT/MCT fat emulsion(Lipofundin)

Sponsors

Tangdu Hospital, The fourth military medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: All patients enrolled in this study are those need radical esophagectomy for esophageal carcinoma, either male or female, the age range from 35 to 70 years old. The informed consent form and ethic committee are necessary before the enrollment.

Exclusion criteria

Exclusion criteria: (1) the patients have taken part in another drug cilincial trial in four weeks; (2) lipid emmusion have been infused for malnutrition in one week; (3) life expectancy less than seven days; (4) contraindication for parenteral nutrition (disturbance of blood coagulation ,unrightable Metabolic disease); (5) known in pregnancy or breastfeeding; (6) patients are potential uncooperative or dont obey the reseach protocol; (7) severe cardiopulmonary insufficiency; (8) severe dyslipdemia (Triglyceride or cholesterol levels are more than 2 times of the upper limit of normal); (9) liver dysfunction (AST level are more than 3 times the upper limit of normal, Severe cholestasis or Conjugated bilirubin level of are more than 2 times the upper limit of normal); (10) Chronic renal failure (the level of BUN and Creatinine exceed 2 times of the upper limit of normal); (11) be allergic to any ingredients or accessories of lipid emmusion(eg. Egg or soybean protein); (12) long history of corticosteroids and immunosuppressive agents; (13) History of preoperative radiotherapy or chemotherapy; (14) Long history of autoimmune disease (Rheumatoid arthritis HIV, SLE et al); (15) disease appears in three months, which have bad effect on the immune system,such as chronic infection.

Design outcomes

Primary

MeasureTime frame
clinical outcome;immune function;Nutrition parameter;liver and renal function tests;blood glucose, cholesterol and triglycerides;

Countries

China

Contacts

Public ContactXiaolong Yan

Tangdu Hospital, The fourth military medical university,

wwp._8@163.com+86 029-84717569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 12, 2026